PLIANT THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PLIANT THERAPEUTICS, INC. (PLRX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $31.05 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-11
- PLIANT THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $31.05M, a 30.31% decline from fiscal 2024.
- PLIANT THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $44.56M, a 7.67% decline from fiscal 2023.
- PLIANT THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $48.26M, a 26.99% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $38.00M, a 17.86% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $31.05M 10-K · filed 2026-03-11 |
| 2024-12-31 | $44.56M 10-K · filed 2026-03-11 |
| 2023-12-31 | $48.26M 10-K · filed 2025-03-03 |
| 2022-12-31 | $38.00M 10-K · filed 2024-02-27 |
| 2021-12-31 | $32.24M 10-K · filed 2023-03-09 |
| 2020-12-31 | $13.51M 10-K · filed 2022-03-01 |
| 2019-12-31 | $1.69M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |